Don’t miss outtag icon
Get early access to Digital 100 2026, Similarweb’s official ranking of the fastest-growing brandsPre-register now!banner icon
Acadia Pharmaceuticals, Inc.

十一月 2025

  • Home
  • Acadia Pharmaceuticals, Inc.

十一月 2025的Acadia Pharmaceuticals, ...市场份额分析

For 30 years, Acadia has been working at the forefront of healthcare to protect what makes you, uniquely you. This is our purpose.
成立年份1993
员工501 - 1000
年营收$500M - $1B
acadia-pharm.com
Acadia Pharmaceuticals, Inc.
Acadia Pharmaceuticals, Inc.(包含公司地区分支机构)
  • acadia-pharm.com
    acadia-pharm.com
查看更多网站流量和参与度信息

Acadia Pharmaceuticals, Inc.收入截至 十一月 2025为 500M - 1B

Acadia Pharmaceuticals, Inc.主要域名产生的收入

3 年中Acadia Pharmaceuticals, Inc.主要域名的收入

Acadia Pharmaceuticals, Inc.主要域名的收入

acadia-pharm.comacadia-pharm.com500M - 1B
使用销售情报查看更多信息

十一月 2025的Acadia Pharmaceuticals, Inc.股票价格

Acadia Pharmaceuticals, Inc.的股票交易代码为 ACAD。您可以在下面查看过去 12 个月的Acadia Pharmaceuticals, Inc.股票表现(最多 十一月 2025)


Acadia Pharmaceuticals, Inc.热门域名的总访问量

了解Acadia Pharmaceuticals, Inc.市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

子公司明细

Acadia Pharmaceuticals, Inc.热门域名的平均访问时长

分析Acadia Pharmaceuticals, Inc.参与度指标。

过去 3 个月的平均访问时长

子公司明细

Acadia Pharmaceuticals, Inc.热门域名的平均页面浏览量

了解Acadia Pharmaceuticals, Inc.如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

子公司明细

想要获取更深入的流量洞见?

过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。



Acadia Pharmaceuticals, Inc. 采用的主要技术

这些是排名前 Acadia Pharmaceuticals, Inc. 的顶级域名所使用的网站技术(按行业分列)

付款和货币 (21)

小部件 (5)

人才招聘 (3)

Greenhouse

Greenhouse

内容管理系统 (2)

WordPress

WordPress

更多技术

8

查看全部

准备好发现优质潜在客户了吗?

借助 Similarweb 销售情报解决方案,确定任意网站使用了哪些技术来设计完美的销售宣传,并缩短销售周期。


Acadia Pharmaceuticals, Inc. 的新闻与信号

借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。

新闻ACADIA Pharmaceuticals Inc. launches magnolia's guide.Acadia Pharmaceuticals announces launch of magnolia's guide to adventuring: A groundbreaking Documentary series aiming to raise disease awareness and redefine perceptions of Rett syndrome.
新闻ACADIA Pharmaceuticals Inc. hired Kevin R. Oliver as Senior Vice President, Chief Business Officer on Jul 10th '23.Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced today the appointment of Dr. Kevin R. Oliver as Senior Vice President, Chief Business Officer, effective July 10, 2023.
新闻ACADIA Pharmaceuticals Inc. launches DAYBUE.Acadia Pharmaceuticals Inc. (Nasdaq: ACAD ) today announced that DAYBUE™ (trofinetide) is now available for the treatment of Rett syndrome in adult and pediatric patients two years of age and older in the United States.

查看 Acadia Pharmaceuticals, Inc. 的所有信号

让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。